|Year : 2020 | Volume
| Issue : 2 | Page : 146-150
Evaluation of lipid profile pattern among apparently healthy students of Niger Delta University
Benedicta Erere Kasia1, Victoria Y Nyondia2, Promise O Oseajeh2, Prohp The Prophet2
1 Department of Chemical Pathology, Niger Delta University, Amassama, Bayelsa, Nigeria
2 Department of Biochemistry, Niger Delta University, Amassama, Bayelsa, Nigeria
|Date of Submission||16-Mar-2020|
|Date of Decision||25-Apr-2020|
|Date of Acceptance||24-Jun-2020|
|Date of Web Publication||31-Dec-2020|
Dr. Benedicta Erere Kasia
Department of Chemical Pathology, Faculty of Basic Medical Sciences, College of Health Sciences, Niger Delta University, Wilberforce Island, P M B 071, Yenagoa, Bayelsa
Source of Support: None, Conflict of Interest: None
Background: Dyslipidemia constitutes a high risk of cardiovascular disease. Aim: This study was designed to evaluate the lipid profile pattern of apparently healthy students of Niger Delta University to detect any possible abnormality. Setting and Design: This was a cross-sectional descriptive study. Materials and Methods: A total of 102 apparently healthy students were studied. A convenient sampling technique was employed for willing participants. The studied group constituted 55 males and 47 females aged within 20–40 years. Relevant demographic data were obtained by a one-on-one interview with the participants. A blood specimen was collected for measurements of total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-c), and low-density lipoprotein cholesterol (LDL-c) by standard assay methods. The data obtained were analyzed using SPSS 22.0, and the student t -test was performed at P < 0.05 for comparison of means. Results: The mean plasma TC and LDL-c values for males were significantly lower than females values of 3.865 ± 0.675 mmol/L versus 4.251 ± 0.851 mmol/L and 2.38 ± 0.49 versus 2.64 ± 0.64 with P = 0.012 and 0.023, respectively. Similarly, the mean plasma HDL-c and TGs for males were lower than female values of 1.126 ± 0.190 mmol/L versus 1.194 ± 0.224 mmol/L and 0.77 ± 0.20 versus 0.82 ± 0.27 with P = 0.099 and 0.27, respectively which were not statistically significant. The age group of 24–27 years constituted the highest mean values and the age group of 28–40 years constituted the least mean values for all the studied parameters. These values, however, did not differ statistically. Most of the participants had significantly within low-normal reference range values. Conclusion: These findings revealed within normal lipid profiles for most subjects.
Keywords: Healthy young students, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol, plasma total cholesterol, triglyceride
|How to cite this article:|
Kasia BE, Nyondia VY, Oseajeh PO, Prophet PT. Evaluation of lipid profile pattern among apparently healthy students of Niger Delta University. Ann Trop Pathol 2020;11:146-50
|How to cite this URL:|
Kasia BE, Nyondia VY, Oseajeh PO, Prophet PT. Evaluation of lipid profile pattern among apparently healthy students of Niger Delta University. Ann Trop Pathol [serial online] 2020 [cited 2022 Oct 3];11:146-50. Available from: https://www.atpjournal.org/text.asp?2020/11/2/146/305684
| Introduction|| |
It is widely acknowledged that Africans globally have one of the highest rates of cardiovascular disease (CVD), and only limited data are available about the distributions of blood lipid concentrations and prevalence of hyperlipidemia in Nigeria. Lipid profile assessment is an important tool to help in the diagnosis of CVDs. Thus, the stability of samples is crucial for the analysis of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c), and triglycerides (TGs). These parameters show a continuous distribution within any population or group, with levels varying with age, sex, race, diet, physical activity, weight, genetic makeup, and environmental factors. Normal homeostasis is required in keeping the concentrations of analytes within an acceptable variation from time to time. CVDs are among the topmost causes of death and disability in adults and one of the main reasons for morbidity with a direct correlation between the serum cholesterol level and incidence of cardiovascular events. Although hypercholesterolemia itself is asymptomatic, long-standing elevation of serum cholesterol can lead to atherosclerosis (hardening of arteries).
Cholesterol (from the Ancient Greek chole [bile] and sterol [solid], followed by the chemical suffix-ol for an alcohol) is an organic molecule. It is a sterol or modified steroid as defined by the US National Library of Medicine, a type of lipid. Cholesterol is a fatty substance essential for normal body functioning. Higher levels of cholesterol in the blood are associated with an increased risk of coronary heart disease (CHD), stroke, and peripheral arterial disease. The Global Burden of Disease Project estimated in 2015, high TC which accounted for 4.3 million deaths globally and the loss of 88.7 million disability-adjusted life years. Globally, the burden attributable to high TC is increasing, probably because of aging populations and westernization of traditional diets. An observational epidemiologic study reported that decreasing levels of TC below those currently considered “normal” would further reduce the risk of CHD and stroke. Elevated levels of non-HDL-c and LDL-c in the blood may be a consequence of diet, obesity, inherited (genetic) diseases (such as LDL receptor mutations in familial hypercholesterolemia), or the presence of other diseases such as type 2 diabetes and an underactive thyroid. Avoiding trans fats and replacing saturated fats in adult diets with polyunsaturated fats are recommended dietary measures to reduce total blood cholesterol and LDL-c in adults. In people with very high LDL cholesterol (e.g., familial hypercholesterolemia), diet is often not sufficient to achieve the desired lowering of LDL-c, and lipid-lowering medications are usually required.
It is not clear if a lower than average cholesterol (hypocholesterolemia) level is directly harmful, A lower than average cholesterol (Hypocholesterolemia) level is often encountered in particular illnesses like adrenal insufficiency, liver disease, malabsoption syndrome such as celiac disease, malnutrition, hypo betalipoproteinemia (a genetic disease that causes cholesterol readings to be less than 50mg/dl). In the elderly, low cholesterol may confer a health risk that may predict short-term mortality., The prevalence of hypocholesterolemia in the elderly ranges between 2% and 36%, depending on the specific cutoff levels and age range investigated.
Elevated levels of TC increase the risk of CHD. TC is measured to help assess the patient's risk status and to follow the progress of patient's treatment to lower serum TC concentrations. Desirable TC levels are considered to be those below 200 mg/dL (5.2 mmol/L) in adults and below 170 mg/dL (4.4 mmol/L) in children.
HDL-c is the smallest of the lipoprotein particles. It is the densest because it contains the highest proportion of protein-to-lipid ratio. Increasing concentrations of HDL particles are strongly associated with decreasing the accumulation of atherosclerosis within the walls of arteries. This is important because atherosclerosis eventually results in sudden plaque ruptures, CVD, stroke, and other vascular diseases. HDL-c is sometimes called “good cholesterol” despite being the same as cholesterol in LDL particles. Those with higher levels of HDL-c tend to have reduced risk with CVDs, while those with low HDL-c levels (especially <40 mg/dL or about 1 mmol/L) have increased risks of heart disease. Higher native HDL-c levels are correlated with better cardiovascular health, but it does not appear that further increasing one's HDL-c improves cardiovascular outcomes (National Institute of Health). Research finding stated that HDL-c in patients with CHD, kidney disease, or diabetes demonstrated no protective vascular effects and was even thought to have some harmful effects. In acute and chronic diseases, the HDL-c composition itself changes, undergoing modification in complex ways. This needs to be considered when interpreting lipid panel results, as it may be misleading to assume an equivalence between HDL-c levels and “good cholesterol.”
In humans, high levels of TGs in the bloodstream have been linked to atherosclerosis and, by extension, the risk of heart disease and stroke. However, the relative negative impact of raised levels of TG compared to that of LDL-c: HDL-c ratio is yet unknown. The risk can be partly accounted for by a strong inverse relationship between TG level and HDL-c. Their levels remain temporarily high for a period after eating; hence, they are best tested after fasting 8–12 h. The American Heart Association recommends optimal TG level of 100 mg/dl (1.1 mmol/L) or lower to improve heart health. High level of TGs is a component of metabolic syndrome (a cluster of conditions that includes too much fat around the waist, high blood pressure, high blood sugar, obesity, and abnormal cholesterol levels). Extremely high TG of >1000 mg/dl (11.29 mmol/L) can cause acute pancreatitis. Certain medications such as beta-blockers, birth control pills, diuretics, or steroids could also increase TGs levels. Low levels will affect the absorption of fat-soluble vitamins (A, D, E, and K). These vitamins are involved in varying metabolism from the cycling of calcium to the production of a beneficial blood clot. The consequence of this is insulin resistance (a hallmark of type 2 DM) and malabsoption syndrome. Any cause of malnutrition like cancer, memory loss, depression, and trauma can deplete the body of fat, thus contributing to low TGs levels.
LDL-c is one of the five major groups of lipoproteins which transports fat molecules around the body in extracellular water. LDL-c delivers fat molecules to cells. It can contribute to atherosclerosis if oxidized within the walls of the arteries. It is important to note that the popular press calls LDL-c a “bad cholesterol.” However, much recent research has shown that it is not necessarily bad because LDL particle appears harmless until they are within the blood vessel walls and oxidized by free radical. It has been stipulated that ingesting antioxidants and minimizing free radical exposure may reduce LDL-c contribution to atherosclerosis, though results are inconclusive.
Our present study aims to evaluate plasma TC, TG, HDL-c, and LDL-c, in apparently healthy young students, males, and females with age ranging from 21 to 40 years of the Niger Delta University, Bayelsa State. There are very few studies on lipid profile in this part of the world. To the best of our knowledge, studies on lipid profile within this age range is scanty in our environment hence the preference. The results from this study will be useful in identifying early morbidities and mortality that may be associated with lipid abnormalities.
| Materials And Methods|| |
Study area and design
This was a cross-sectional study carried out among the students of the Faculty of Basic Medical Sciences, College of Health Sciences, Niger Delta University, Bayelsa State. A total of 102 apparently healthy students aged within 20–40 years were recruited for the study. The selection of participants for the study was done by a convenient sampling method of readily available consenting students.
Ethical approval was sought and obtained for this study from the Niger Delta University Ethical Committee after explaining the objectives and benefits of the study. Written and informed consent was sought and obtained from each participant before the study.
Participants selection and exclusion
Apparently healthy students aged within 21–40 years who gave informed consent to participate in the study were selected for the study, while students with known medical conditions such as renal disorders, heart disease, and diabetes mellitus and students who declined study participation were excluded from the study.
Relevant information such as age, sex, tribe, and religion were obtained through a one-on-one interview from each participant for their demographic data.
Specimen Collection and Storage: About 4 ml of free-flowing venous blood was obtained after 12 h fast (at 8.00 am the next morning) from the antecubital vein by routine aseptic technique without a tourniquet. The blood was dispersed into lithium heparin specimen bottles and thereafter centrifuged at 3500 rpm for 10 min. The plasma was harvested with a clean Pasteur pipette into plane bottles and stored frozen in a deep freezer (at −20°C) until the analysis was done within 24 h of collection.
Measurements of biochemical parameters
The measured plasma lipids such as TC, TG, HDL-c, and LDL-c were analyzed using standard assay methods (enzymatic endpoint, hydrolysis, precipitation methods, and Friedwald's formula, respectively). Hemolyzed and visibly lipemic samples were excluded. All assays were performed in duplicates and quality control sera were analyzed in each batch and the intra- and inter-assay coefficients of variations were 5% and 8%, respectively, in our laboratory. All reference intervals were interpreted in accordance with established procedures. TC = 3.5–6.5 mmol/L, TG = 0.5–2.2 mmol/L, HDL-c = >0.9 mmol/L, and LDL-c = 2.0–3.5 mmol/L were normal reference values.
The statistical analysis was performed using SPSS version 23 software application. The mean and standard deviation were determined for quantitative data. Percentage frequencies were used for categorical variables. The differences in means were compared using the student t -test. Statistically significant probability or P value was set at 0.05 or 5% confidence interval.
No conflict of interest was declared by the authors.
| Results|| |
Demographic data of participants
A total of 102 respondents which comprises 55 males and 47 females were interviewed. The age groups were between 20 and 40 years. A total of 61 (59.8%) respondents were aged between 20 and 23 years which comprises 28 (45.9%) males and 33 (54.1%) females. About 33 (32.4%) of the respondents were between 24 and 27 years which comprises 21 (64%) males and 12 (36%) females. While, a total of 8 (7.8%) of participants were between 28-40 years.
The mean plasma TC and LDL-c values for males were significantly lower than females values of 3.865 ± 0.675 mmol/L versus 4.251 ± 0.851 mmol/L and 2.38 ± 0.49 versus 2.64 ± 0.64, with P = 0.012 and 0.023, respectively. Similarly, the mean plasma HDL-c and TGs for males were lower than female values of 1.126 ± 0.190 mmol/L versus 1.194 ± 0.224 mmol/L and 0.77 ± 0.20 versus 0.82 ± 0.27, with P = 0.099 and 0.27, respectively, which were not statistically significant, [Table 1].
|Table 1: Comparison of mean plasma total cholesterol, high-density lipoprotein cholesterol, TG, and low-density lipoprotein cholesterol levels in participants by gender|
Click here to view
Comparison of mean plasma total cholesterol, high-density lipoprotein cholesterol, triglyceride, and low-density lipoprotein cholesterol levels in participants by age groups
The age group of 24–27 years constituted the highest mean values and 28–40 years the least mean values for all the studied parameters. These values, however, did not differ statistically, [Table 2].
|Table 2: Comparison of mean plasma total cholesterol, high-density lipoprotein cholesterol, triglyceride, and low-density lipoprotein cholesterol in participants by age groups|
Click here to view
Percentage frequency distribution plasma total cholesterol, high-density lipoprotein cholesterol, triglyceride, and low-density lipoprotein cholesterol in participants based on our laboratory reference intervals
Majority of the participants had significantly within low-normal reference range values as in 77/102 (75.5%), 74/102 (72.5%), 97/102 (95%), and 76/102 (75%) in terms of TC, HDL-c, TG, and LDL cholesterol values, respectively. In addition to this, up to about 28/102 (27.5%) of the studied group had high levels of HDL (good cholesterol).
| Discussion|| |
Over the years, the growing epidemic of childhood and adult obesity, insulin resistance, type 2 diabetes mellitus, and dyslipidemia has led to atherosclerotic CVD which remains the leading cause of death and disability in the Western world. The four elements of fat metabolism such as TC, LDL-c, HDL-c, and TG are known to affect the development of heart disease. Over a period of time, elevated levels of plasma TC contribute to the formation of atheromatous plaque, especially over small arteries which may rupture and cause a clot to form. This could obstruct blood flow as in the coronary arteries with a resultant heart attack.
In this study, it was observed that the participants aged within 24–27 years had the highest mean values for TC, HDL-c, LDL-c, and TG. This is comparable with studies by Zhao et al . where higher age groups tend to have lower TC levels. Contrary to this are findings by Bushnell and Ngwogwu et al . who reported that TC and HDL-c were higher in the older age groups. The effect of age on lipid profile could not be explained; hence, it demands further studies.
In an attempt to establish gender relationship to lipid profile in this study, it was observed that the female values were more than the males. This is in keeping with studies by Ofori et al . and Madhumita and Mauchumi whose study was with reference to age and sex whereby HDL-c and TC values increased with increasing age with higher values in females than males. The higher HDL-c value in the females may be attributable to the cardioprotective effects of estrogen through glucose metabolism and hemostatic system at younger age, and it may also have an effect on endothelial function. While the differential higher levels of TC in females could not be explained, but there was a hypothetical finding by Kautzky-Willer et al ., stating gender-specific lipid-lowering resistance in females leading to defective lipid metabolism in females than males.
This study also showed that the majority of the participants had significantly within low-normal reference range values as in 77 (75.5%), 74 (72.5%), 97 (95%), and 76 (75%) in terms of TC, HDL-c, TG, and LDL cholesterol values, respectively Impute [Figure 1]. This is in keeping with a study done by Kasia and Idogun on the frequency of atherogenic risk in type 2 diabetes mellitus and healthy controls which reported a high percentage of low risk in the healthy controls as 80%, 79%, 94%, and 86% for TC, HDL, TG, and LDL cholesterol values, respectively. In addition to this, up to about 28 (27.5%) of the studied group had high levels of HDL (good cholesterol). This finding also corroborates with that of Solomon et al . who found a high percentage of participants within desirable (low-normal) TC levels. These findings support low cardiovascular risk among the studied participants.
|Figure 1: Percentage-frequency distribution: plasma TC, HDL-c, TG, and LDL-c in participants into normal, low and high values based on our laboratory reference intervals. TC: Total cholesterol, HDL-c: High-density lipoprotein cholesterol, TG: Triglyceride, LDL-c: Low-density lipoprotein cholesterol|
Click here to view
| Conclusion|| |
These findings revealed that majority of the participants had within normal lipid profile in keeping with good health status.
Dyslipidemia is one of the highest risk factors for CVD; hence, it is suggested that all adults 20 years of age or older should have a fasting lipid profile (TC, LDL-c, HDL-c, and TG) performed at least once every 5 years and more often if the profile is abnormal. Patients who have had an acute event (e.g., myocardial infarction), a percutaneous coronary intervention, or a coronary artery bypass graft require assessment of their LDL cholesterol level within a few months of the event or procedure because LDL levels may be low immediately after the acute event or procedure. Subsequently, lipids should be monitored every 6 weeks until the desired level is achieved and then every 4–6 months. These measures will, in the long run, detect new cases for treatment or prevent complications of CVD if any.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Kountz DS, Levine SL. Cardiovascular risk profiling in blacks: Don't forget the lipids. Am Fam Phys 1998;58:1541-2.
Dahiru T, Ejembi CI, Adamu MY, Abubakar A. Serum lipids profiles and pattern of hyperlipidaemia in a semi- urban community in Northern Nigeria. Niger J Med 2007;48:51-4.
Akpa MR, Agomouh DI, Alasia DD. Lipid profile of healthy adult Nigerians in Port Harcourt, Nigeria. Niger J Med 2006;15:137-40.
Daniels TF, Killinger KM, Michal JJ ,Wright Jr.RW and Jiang Z. Lipoproteins, cholesterol homeostasis and cardiac health. Int.J Biol Sci2009;5:474-88.
Ravi BV, Ushas SM. Serum magnesium levels in patients with hypertension. J Clin Sci 2014;4:282-5.
Bhatnagar D, Soran H, Durrington PN. Hypercholesterolaemia and its management. BMJ 2008;337:A993.
Forouzanfar M, Afshin A, Alexander LT. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clustersof risks, 1990-2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388:1659-724.
Huxley R, Lewington S, Clarke R. Cholesterol, coronary heart disease and stroke: A review of published evidence from observational studies and randomized controlled trials. Semin Vasc Med 2002;2:315-23.
Durrington P. Dyslipidaemia. Lancet 2003;362:717-31.
De Souza RJ, Mente A, Maroleanu A, Cozma AI, Ha V, Kishibe T, et al
. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: Systematic review and meta-analysis of observational studies. BMJ 2015;351:H3978.
Ito MK, McGowan MP, Moriarty PM, National Lipid Association Expert Panel on Familial Hypercholesterolemia. Management of familial hypercholesterolemias in adult patients: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol 2011;5:S38-45.
Moutzouri E, Elisaf M, Liberopoulos EN. Hypocholesterolemia. Curr Vasc Pharmacol 2011;9:200-12.
Schatz IJ, Masaki K, Yano K, Chen R, Rodriguez BL, Curb JD. Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: A cohort study. Lancet 2001;358:351-5.
Onder G, Landi F,Volpato S, Fellin R, Carbonin P, Gambasi G and Bernabei R. Serum cholesterol levels and in-hospital mortality in the elderly. Am J Med 2003;115: 265-71.
Tsabar N, Press Y, Rotman J, Klein B, Grossman Y, Vainshtein-Tal M, et al
. The low indexes of metabolism intervention trial (LIMIT): Design and baseline data of a randomized controlledclinical trial to evaluate how alerting primary care teams to low metabolic values, could affect the health of patients aged 75 or older. BMC Health Serv Res 2018;18:4.
John S, Sorokin A, Thompson P. Phytosterols and vascular disease. Curr Opinion Lipidol 2007;18:35-40.
Toth PP. Cardiology patient page. The good cholesterol: High-density lipoprotein. Circulation 2005;111:E89-91.
Sirtori CR. HDL-c and the progression of atherosclerosis: new insights, European Heart Journal Supplements, Volume 8, issue suppl_F, 1st
National Institute of Health. National Heart, Lung, and Blood Institute (NHLBI).”NIH Stops Clinical Trial on Combination Cholesterol Treatment. Retrieved; 02 June, 2011.
März W, Kleber ME, Scharnagl H, Speer T, Zewinger S, Ritsch A, et al
. HDL cholesterol: Reappraisal of its clinical relevance. Clin Res Cardiol 2017;106:663-75.
Drummond KE, Brefere LM. Nutrition for Food Service and Culinary Professionals. 8th
ed. New York, U.S.A: John Wiley and Sons; 2014.
Nordestgaard BG, Benn M, Schnohr P. Non fasting Triglycerides and risk of myocardial infarction, ischaemic heart disease and death in men and women. JAMA 2007;298:299-308.
Centers for Disease Control and Prevention. CDC. LDL and HDL: Bad and Good Cholesterol. Retrieved; 11 September, 2017.
Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004;84:1381-478.
Zak B. Cholesterol methodologies: A review. Clin Chem 1977;23:1201-14.
Warnick GR, Cheung MC, Albers JJ. Comparison of current methods for high-density lipoprotein cholesterol quantitation. Clin Chem 1979;25:596-604.
Klotsch SG, McNamara JR. Triglyceride measurement. A review of methods and interferences. Clin Chem 1990;36:1605-13.
Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concerntration of low density lipoprotein cholesterol without use of preparative ultracentrifuge. Clin Chem 1972;18:499-504.
Lewandrowski K, Kratz K. Case records of the massachusetts general hospital: Normal reference values. N Engl J Med 1999;339:1063-72.
Lloyd-Jones D, Adams RJ, Brown TM. Heart disease and stroke statistics-2010 update: A report from the American heart association. Circulation 2010;121:e46-215.
Brunner F, Saddarth H. Function of liver. In: Text Book on Mdical-Surgical Nursing. 12th
ed. Philadelphia: Lippincott Williams and Wilkins; 2010. p. 758-9.
Finn AV, Nakano M, Narula J, Kolodgie F, Virmani R. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 2010;30:1282-92.
Zhao P, Liu S, Zhong Z and Liu J. Age and sex related difference of lipid profile in patients with ischemic stroke in China. Medicine 2018; 97:e10930.
Bushnell CD. Stroke and the female brain. Nat Clin Pract Neurol 2008;4:22-33.
Ngwogwu KO, Ekpo BO, Akpuaka FC, Ngwogu AC. Lipid profile of apparently healthy adults in abametroplis, South Eastern Nigeria. Int J Basic Appl Innovat Res 2013;2:85-91.
Ofori EK, Intiful FD, Matilda A, George A, Patrick KA, Rebecca KS, et al
. Prevalence of cardiovascular disease risk factors among students of a tertiary institution in Ghana. Food Sci.Nutr 2018;6:381-7.
Madhumita D, Mauchumi S. Estimation of reference interval of llipid profile in assamesa populqtion. Indian J Clin Biochem 2009;24:190-3.
Kautzky-Willer A, Kamyar MR, Gerhat D, Handisurya A, Stemer G, Hudson S, et al
. Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus. Gend Med 2010;7:571-83.
Kasia BE, Idogun ES. Frequency of atherogenic risk in type 2 diabetes mellitus and non-diabetes mellitus patients. Ann Biomed Sci 2012;11:40-7.
Solomon MU, Bonnie KG, Tabowei OC, Ngaikedi FN. The serum cholesterol and blood pressure of selected adults in Bayelsa State, Nigeria. Europ J Pharm Med Res 2017;4:39-44.
[Table 1], [Table 2]